カテゴリ： 世界, 医療/バイオ, QYResearch

カナグリフロジン半水和物の世界市場2023年：高純度カナグリフロジン半水和物、超高純度カナグリフロジン半水和物

■ 英語タイトル：Global Canagliflozin Hemihydrate Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8707）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8707
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：106
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[カナグリフロジン半水和物の世界市場2023年：高純度カナグリフロジン半水和物、超高純度カナグリフロジン半水和物]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はカナグリフロジン半水和物のグローバル市場について調査・分析し、世界のカナグリフロジン半水和物市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（高純度カナグリフロジン半水和物、超高純度カナグリフロジン半水和物）、用途別セグメント分析（病院、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Hefei Home Sunshine Pharmaceutical Technology、Akkgen Bio、Hangzhou Dawn Ray Pharmaceutical、ACE Biolabs、Beijing Huikang Boyuan Chemical Tech、Shanghai Yuhan Chemical、DC Chemicals、Adooq Bioscience、Dr. Reddy's、Carbosynth、Toronto Research Chemicals、Selleck Chemicals、SimSon Pharma、VIVAN Life Sciences、InvivoChem、Clinivex、Aprazer Healthcareなどが含まれています。カナグリフロジン半水和物のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、カナグリフロジン半水和物市場規模を算出する際に考慮しました。

・カナグリフロジン半水和物市場の概要
- 製品の定義
- カナグリフロジン半水和物の種類別セグメント
- 世界のカナグリフロジン半水和物市場規模：タイプ別分析（高純度カナグリフロジン半水和物、超高純度カナグリフロジン半水和物）
- カナグリフロジン半水和物の用途別セグメント
- 世界のカナグリフロジン半水和物市場規模：用途別分析（病院、診療所、その他）
- 世界のカナグリフロジン半水和物市場規模予測（2018年-2029年）
- カナグリフロジン半水和物の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- カナグリフロジン半水和物市場の競争状況およびトレンド

・カナグリフロジン半水和物の地域別市場規模
- 北米のカナグリフロジン半水和物市場規模（2018年-2029年）
- 米国のカナグリフロジン半水和物市場規模（2018年-2029年）
- ヨーロッパのカナグリフロジン半水和物市場規模（2018年-2029年）
- アジア太平洋のカナグリフロジン半水和物市場規模（2018年-2029年）
- 中国のカナグリフロジン半水和物市場規模（2018年-2029年）
- 日本のカナグリフロジン半水和物市場規模（2018年-2029年）
- 韓国のカナグリフロジン半水和物市場規模（2018年-2029年）
- インドのカナグリフロジン半水和物市場規模（2018年-2029年）
- オーストラリアのカナグリフロジン半水和物市場規模（2018年-2029年）
- 中南米のカナグリフロジン半水和物市場規模（2018年-2029年）
- 中東・アフリカのカナグリフロジン半水和物市場規模（2018年-2029年）

・種類別セグメント：高純度カナグリフロジン半水和物、超高純度カナグリフロジン半水和物
- 世界のカナグリフロジン半水和物のタイプ別販売量（2018年-2023年）
- 世界のカナグリフロジン半水和物のタイプ別売上（2018年-2023年）
- 世界のカナグリフロジン半水和物のタイプ別価格

・用途別セグメント：病院、診療所、その他
- 世界のカナグリフロジン半水和物の用途別販売量（2018年-2023年）
- 世界のカナグリフロジン半水和物の用途別売上（2018年-2023年）
- 世界のカナグリフロジン半水和物の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Hefei Home Sunshine Pharmaceutical Technology、Akkgen Bio、Hangzhou Dawn Ray Pharmaceutical、ACE Biolabs、Beijing Huikang Boyuan Chemical Tech、Shanghai Yuhan Chemical、DC Chemicals、Adooq Bioscience、Dr. Reddy's、Carbosynth、Toronto Research Chemicals、Selleck Chemicals、SimSon Pharma、VIVAN Life Sciences、InvivoChem、Clinivex、Aprazer Healthcare

・産業チェーンと販売チャネルの分析
- カナグリフロジン半水和物産業チェーン分析
- カナグリフロジン半水和物の主要原材料
- カナグリフロジン半水和物の販売チャネル
- カナグリフロジン半水和物のディストリビューター
- カナグリフロジン半水和物の主要顧客

・カナグリフロジン半水和物市場ダイナミクス
- カナグリフロジン半水和物の業界動向
- カナグリフロジン半水和物市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Canagliflozin Hemihydrate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Canagliflozin Hemihydrate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Canagliflozin Hemihydrate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Canagliflozin Hemihydrate include Hefei Home Sunshine Pharmaceutical Technology, Akkgen Bio, Hangzhou Dawn Ray Pharmaceutical, ACE Biolabs, Beijing Huikang Boyuan Chemical Tech, Shanghai Yuhan Chemical, DC Chemicals, Adooq Bioscience and Dr. Reddy’s, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Canagliflozin Hemihydrate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canagliflozin Hemihydrate.
The Canagliflozin Hemihydrate market size, estimations, and forecasts are provided in terms of sales volume (MG) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Canagliflozin Hemihydrate market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canagliflozin Hemihydrate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Hefei Home Sunshine Pharmaceutical Technology
Akkgen Bio
Hangzhou Dawn Ray Pharmaceutical
ACE Biolabs
Beijing Huikang Boyuan Chemical Tech
Shanghai Yuhan Chemical
DC Chemicals
Adooq Bioscience
Dr. Reddy’s
Carbosynth
Toronto Research Chemicals
Selleck Chemicals
SimSon Pharma
VIVAN Life Sciences
InvivoChem
Clinivex
Aprazer Healthcare
Segment by Type
High Purity Canagliflozin Hemihydrate
Ultra High Purity Canagliflozin Hemihydrate
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Canagliflozin Hemihydrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Canagliflozin Hemihydrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Canagliflozin Hemihydrate Market Overview
1.1 Product Overview and Scope of Canagliflozin Hemihydrate
1.2 Canagliflozin Hemihydrate Segment by Type
1.2.1 Global Canagliflozin Hemihydrate Market Value Comparison by Type (2023-2029)
1.2.2 High Purity Canagliflozin Hemihydrate
1.2.3 Ultra High Purity Canagliflozin Hemihydrate
1.3 Canagliflozin Hemihydrate Segment by Application
1.3.1 Global Canagliflozin Hemihydrate Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Canagliflozin Hemihydrate Market Size Estimates and Forecasts
1.4.1 Global Canagliflozin Hemihydrate Revenue 2018-2029
1.4.2 Global Canagliflozin Hemihydrate Sales 2018-2029
1.4.3 Global Canagliflozin Hemihydrate Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Canagliflozin Hemihydrate Market Competition by Manufacturers
2.1 Global Canagliflozin Hemihydrate Sales Market Share by Manufacturers (2018-2023)
2.2 Global Canagliflozin Hemihydrate Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Canagliflozin Hemihydrate Average Price by Manufacturers (2018-2023)
2.4 Global Canagliflozin Hemihydrate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Canagliflozin Hemihydrate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Canagliflozin Hemihydrate, Product Type & Application
2.7 Canagliflozin Hemihydrate Market Competitive Situation and Trends
2.7.1 Canagliflozin Hemihydrate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Canagliflozin Hemihydrate Players Market Share by Revenue
2.7.3 Global Canagliflozin Hemihydrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Canagliflozin Hemihydrate Retrospective Market Scenario by Region
3.1 Global Canagliflozin Hemihydrate Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Canagliflozin Hemihydrate Global Canagliflozin Hemihydrate Sales by Region: 2018-2029
3.2.1 Global Canagliflozin Hemihydrate Sales by Region: 2018-2023
3.2.2 Global Canagliflozin Hemihydrate Sales by Region: 2024-2029
3.3 Global Canagliflozin Hemihydrate Global Canagliflozin Hemihydrate Revenue by Region: 2018-2029
3.3.1 Global Canagliflozin Hemihydrate Revenue by Region: 2018-2023
3.3.2 Global Canagliflozin Hemihydrate Revenue by Region: 2024-2029
3.4 North America Canagliflozin Hemihydrate Market Facts & Figures by Country
3.4.1 North America Canagliflozin Hemihydrate Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Canagliflozin Hemihydrate Sales by Country (2018-2029)
3.4.3 North America Canagliflozin Hemihydrate Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Canagliflozin Hemihydrate Market Facts & Figures by Country
3.5.1 Europe Canagliflozin Hemihydrate Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Canagliflozin Hemihydrate Sales by Country (2018-2029)
3.5.3 Europe Canagliflozin Hemihydrate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Canagliflozin Hemihydrate Market Facts & Figures by Country
3.6.1 Asia Pacific Canagliflozin Hemihydrate Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Canagliflozin Hemihydrate Sales by Country (2018-2029)
3.6.3 Asia Pacific Canagliflozin Hemihydrate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Canagliflozin Hemihydrate Market Facts & Figures by Country
3.7.1 Latin America Canagliflozin Hemihydrate Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Canagliflozin Hemihydrate Sales by Country (2018-2029)
3.7.3 Latin America Canagliflozin Hemihydrate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Canagliflozin Hemihydrate Market Facts & Figures by Country
3.8.1 Middle East and Africa Canagliflozin Hemihydrate Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Canagliflozin Hemihydrate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Canagliflozin Hemihydrate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Canagliflozin Hemihydrate Sales by Type (2018-2029)
4.1.1 Global Canagliflozin Hemihydrate Sales by Type (2018-2023)
4.1.2 Global Canagliflozin Hemihydrate Sales by Type (2024-2029)
4.1.3 Global Canagliflozin Hemihydrate Sales Market Share by Type (2018-2029)
4.2 Global Canagliflozin Hemihydrate Revenue by Type (2018-2029)
4.2.1 Global Canagliflozin Hemihydrate Revenue by Type (2018-2023)
4.2.2 Global Canagliflozin Hemihydrate Revenue by Type (2024-2029)
4.2.3 Global Canagliflozin Hemihydrate Revenue Market Share by Type (2018-2029)
4.3 Global Canagliflozin Hemihydrate Price by Type (2018-2029)
5 Segment by Application
5.1 Global Canagliflozin Hemihydrate Sales by Application (2018-2029)
5.1.1 Global Canagliflozin Hemihydrate Sales by Application (2018-2023)
5.1.2 Global Canagliflozin Hemihydrate Sales by Application (2024-2029)
5.1.3 Global Canagliflozin Hemihydrate Sales Market Share by Application (2018-2029)
5.2 Global Canagliflozin Hemihydrate Revenue by Application (2018-2029)
5.2.1 Global Canagliflozin Hemihydrate Revenue by Application (2018-2023)
5.2.2 Global Canagliflozin Hemihydrate Revenue by Application (2024-2029)
5.2.3 Global Canagliflozin Hemihydrate Revenue Market Share by Application (2018-2029)
5.3 Global Canagliflozin Hemihydrate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Hefei Home Sunshine Pharmaceutical Technology
6.1.1 Hefei Home Sunshine Pharmaceutical Technology Corporation Information
6.1.2 Hefei Home Sunshine Pharmaceutical Technology Description and Business Overview
6.1.3 Hefei Home Sunshine Pharmaceutical Technology Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Hefei Home Sunshine Pharmaceutical Technology Canagliflozin Hemihydrate Product Portfolio
6.1.5 Hefei Home Sunshine Pharmaceutical Technology Recent Developments/Updates
6.2 Akkgen Bio
6.2.1 Akkgen Bio Corporation Information
6.2.2 Akkgen Bio Description and Business Overview
6.2.3 Akkgen Bio Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Akkgen Bio Canagliflozin Hemihydrate Product Portfolio
6.2.5 Akkgen Bio Recent Developments/Updates
6.3 Hangzhou Dawn Ray Pharmaceutical
6.3.1 Hangzhou Dawn Ray Pharmaceutical Corporation Information
6.3.2 Hangzhou Dawn Ray Pharmaceutical Description and Business Overview
6.3.3 Hangzhou Dawn Ray Pharmaceutical Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Hangzhou Dawn Ray Pharmaceutical Canagliflozin Hemihydrate Product Portfolio
6.3.5 Hangzhou Dawn Ray Pharmaceutical Recent Developments/Updates
6.4 ACE Biolabs
6.4.1 ACE Biolabs Corporation Information
6.4.2 ACE Biolabs Description and Business Overview
6.4.3 ACE Biolabs Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ACE Biolabs Canagliflozin Hemihydrate Product Portfolio
6.4.5 ACE Biolabs Recent Developments/Updates
6.5 Beijing Huikang Boyuan Chemical Tech
6.5.1 Beijing Huikang Boyuan Chemical Tech Corporation Information
6.5.2 Beijing Huikang Boyuan Chemical Tech Description and Business Overview
6.5.3 Beijing Huikang Boyuan Chemical Tech Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Beijing Huikang Boyuan Chemical Tech Canagliflozin Hemihydrate Product Portfolio
6.5.5 Beijing Huikang Boyuan Chemical Tech Recent Developments/Updates
6.6 Shanghai Yuhan Chemical
6.6.1 Shanghai Yuhan Chemical Corporation Information
6.6.2 Shanghai Yuhan Chemical Description and Business Overview
6.6.3 Shanghai Yuhan Chemical Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Shanghai Yuhan Chemical Canagliflozin Hemihydrate Product Portfolio
6.6.5 Shanghai Yuhan Chemical Recent Developments/Updates
6.7 DC Chemicals
6.6.1 DC Chemicals Corporation Information
6.6.2 DC Chemicals Description and Business Overview
6.6.3 DC Chemicals Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 DC Chemicals Canagliflozin Hemihydrate Product Portfolio
6.7.5 DC Chemicals Recent Developments/Updates
6.8 Adooq Bioscience
6.8.1 Adooq Bioscience Corporation Information
6.8.2 Adooq Bioscience Description and Business Overview
6.8.3 Adooq Bioscience Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Adooq Bioscience Canagliflozin Hemihydrate Product Portfolio
6.8.5 Adooq Bioscience Recent Developments/Updates
6.9 Dr. Reddy’s
6.9.1 Dr. Reddy’s Corporation Information
6.9.2 Dr. Reddy’s Description and Business Overview
6.9.3 Dr. Reddy’s Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Dr. Reddy’s Canagliflozin Hemihydrate Product Portfolio
6.9.5 Dr. Reddy’s Recent Developments/Updates
6.10 Carbosynth
6.10.1 Carbosynth Corporation Information
6.10.2 Carbosynth Description and Business Overview
6.10.3 Carbosynth Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Carbosynth Canagliflozin Hemihydrate Product Portfolio
6.10.5 Carbosynth Recent Developments/Updates
6.11 Toronto Research Chemicals
6.11.1 Toronto Research Chemicals Corporation Information
6.11.2 Toronto Research Chemicals Canagliflozin Hemihydrate Description and Business Overview
6.11.3 Toronto Research Chemicals Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Toronto Research Chemicals Canagliflozin Hemihydrate Product Portfolio
6.11.5 Toronto Research Chemicals Recent Developments/Updates
6.12 Selleck Chemicals
6.12.1 Selleck Chemicals Corporation Information
6.12.2 Selleck Chemicals Canagliflozin Hemihydrate Description and Business Overview
6.12.3 Selleck Chemicals Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Selleck Chemicals Canagliflozin Hemihydrate Product Portfolio
6.12.5 Selleck Chemicals Recent Developments/Updates
6.13 SimSon Pharma
6.13.1 SimSon Pharma Corporation Information
6.13.2 SimSon Pharma Canagliflozin Hemihydrate Description and Business Overview
6.13.3 SimSon Pharma Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.13.4 SimSon Pharma Canagliflozin Hemihydrate Product Portfolio
6.13.5 SimSon Pharma Recent Developments/Updates
6.14 VIVAN Life Sciences
6.14.1 VIVAN Life Sciences Corporation Information
6.14.2 VIVAN Life Sciences Canagliflozin Hemihydrate Description and Business Overview
6.14.3 VIVAN Life Sciences Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.14.4 VIVAN Life Sciences Canagliflozin Hemihydrate Product Portfolio
6.14.5 VIVAN Life Sciences Recent Developments/Updates
6.15 InvivoChem
6.15.1 InvivoChem Corporation Information
6.15.2 InvivoChem Canagliflozin Hemihydrate Description and Business Overview
6.15.3 InvivoChem Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.15.4 InvivoChem Canagliflozin Hemihydrate Product Portfolio
6.15.5 InvivoChem Recent Developments/Updates
6.16 Clinivex
6.16.1 Clinivex Corporation Information
6.16.2 Clinivex Canagliflozin Hemihydrate Description and Business Overview
6.16.3 Clinivex Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Clinivex Canagliflozin Hemihydrate Product Portfolio
6.16.5 Clinivex Recent Developments/Updates
6.17 Aprazer Healthcare
6.17.1 Aprazer Healthcare Corporation Information
6.17.2 Aprazer Healthcare Canagliflozin Hemihydrate Description and Business Overview
6.17.3 Aprazer Healthcare Canagliflozin Hemihydrate Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Aprazer Healthcare Canagliflozin Hemihydrate Product Portfolio
6.17.5 Aprazer Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Canagliflozin Hemihydrate Industry Chain Analysis
7.2 Canagliflozin Hemihydrate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Canagliflozin Hemihydrate Production Mode & Process
7.4 Canagliflozin Hemihydrate Sales and Marketing
7.4.1 Canagliflozin Hemihydrate Sales Channels
7.4.2 Canagliflozin Hemihydrate Distributors
7.5 Canagliflozin Hemihydrate Customers
8 Canagliflozin Hemihydrate Market Dynamics
8.1 Canagliflozin Hemihydrate Industry Trends
8.2 Canagliflozin Hemihydrate Market Drivers
8.3 Canagliflozin Hemihydrate Market Challenges
8.4 Canagliflozin Hemihydrate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Canagliflozin Hemihydrate Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Canagliflozin Hemihydrate Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Canagliflozin Hemihydrate Market Competitive Situation by Manufacturers in 2022
Table 4. Global Canagliflozin Hemihydrate Sales (MG) of Key Manufacturers (2018-2023)
Table 5. Global Canagliflozin Hemihydrate Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Canagliflozin Hemihydrate Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Canagliflozin Hemihydrate Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Canagliflozin Hemihydrate Average Price (US$/MG) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Canagliflozin Hemihydrate, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Canagliflozin Hemihydrate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Canagliflozin Hemihydrate, Product Type & Application
Table 12. Global Key Manufacturers of Canagliflozin Hemihydrate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Canagliflozin Hemihydrate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canagliflozin Hemihydrate as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Canagliflozin Hemihydrate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Canagliflozin Hemihydrate Sales by Region (2018-2023) & (MG)
Table 18. Global Canagliflozin Hemihydrate Sales Market Share by Region (2018-2023)
Table 19. Global Canagliflozin Hemihydrate Sales by Region (2024-2029) & (MG)
Table 20. Global Canagliflozin Hemihydrate Sales Market Share by Region (2024-2029)
Table 21. Global Canagliflozin Hemihydrate Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Canagliflozin Hemihydrate Revenue Market Share by Region (2018-2023)
Table 23. Global Canagliflozin Hemihydrate Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Canagliflozin Hemihydrate Revenue Market Share by Region (2024-2029)
Table 25. North America Canagliflozin Hemihydrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Canagliflozin Hemihydrate Sales by Country (2018-2023) & (MG)
Table 27. North America Canagliflozin Hemihydrate Sales by Country (2024-2029) & (MG)
Table 28. North America Canagliflozin Hemihydrate Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Canagliflozin Hemihydrate Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Canagliflozin Hemihydrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Canagliflozin Hemihydrate Sales by Country (2018-2023) & (MG)
Table 32. Europe Canagliflozin Hemihydrate Sales by Country (2024-2029) & (MG)
Table 33. Europe Canagliflozin Hemihydrate Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Canagliflozin Hemihydrate Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Canagliflozin Hemihydrate Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Canagliflozin Hemihydrate Sales by Region (2018-2023) & (MG)
Table 37. Asia Pacific Canagliflozin Hemihydrate Sales by Region (2024-2029) & (MG)
Table 38. Asia Pacific Canagliflozin Hemihydrate Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Canagliflozin Hemihydrate Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Canagliflozin Hemihydrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Canagliflozin Hemihydrate Sales by Country (2018-2023) & (MG)
Table 42. Latin America Canagliflozin Hemihydrate Sales by Country (2024-2029) & (MG)
Table 43. Latin America Canagliflozin Hemihydrate Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Canagliflozin Hemihydrate Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Canagliflozin Hemihydrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Canagliflozin Hemihydrate Sales by Country (2018-2023) & (MG)
Table 47. Middle East & Africa Canagliflozin Hemihydrate Sales by Country (2024-2029) & (MG)
Table 48. Middle East & Africa Canagliflozin Hemihydrate Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Canagliflozin Hemihydrate Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Canagliflozin Hemihydrate Sales (MG) by Type (2018-2023)
Table 51. Global Canagliflozin Hemihydrate Sales (MG) by Type (2024-2029)
Table 52. Global Canagliflozin Hemihydrate Sales Market Share by Type (2018-2023)
Table 53. Global Canagliflozin Hemihydrate Sales Market Share by Type (2024-2029)
Table 54. Global Canagliflozin Hemihydrate Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Canagliflozin Hemihydrate Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Canagliflozin Hemihydrate Revenue Market Share by Type (2018-2023)
Table 57. Global Canagliflozin Hemihydrate Revenue Market Share by Type (2024-2029)
Table 58. Global Canagliflozin Hemihydrate Price (US$/MG) by Type (2018-2023)
Table 59. Global Canagliflozin Hemihydrate Price (US$/MG) by Type (2024-2029)
Table 60. Global Canagliflozin Hemihydrate Sales (MG) by Application (2018-2023)
Table 61. Global Canagliflozin Hemihydrate Sales (MG) by Application (2024-2029)
Table 62. Global Canagliflozin Hemihydrate Sales Market Share by Application (2018-2023)
Table 63. Global Canagliflozin Hemihydrate Sales Market Share by Application (2024-2029)
Table 64. Global Canagliflozin Hemihydrate Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Canagliflozin Hemihydrate Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Canagliflozin Hemihydrate Revenue Market Share by Application (2018-2023)
Table 67. Global Canagliflozin Hemihydrate Revenue Market Share by Application (2024-2029)
Table 68. Global Canagliflozin Hemihydrate Price (US$/MG) by Application (2018-2023)
Table 69. Global Canagliflozin Hemihydrate Price (US$/MG) by Application (2024-2029)
Table 70. Hefei Home Sunshine Pharmaceutical Technology Corporation Information
Table 71. Hefei Home Sunshine Pharmaceutical Technology Description and Business Overview
Table 72. Hefei Home Sunshine Pharmaceutical Technology Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 73. Hefei Home Sunshine Pharmaceutical Technology Canagliflozin Hemihydrate Product
Table 74. Hefei Home Sunshine Pharmaceutical Technology Recent Developments/Updates
Table 75. Akkgen Bio Corporation Information
Table 76. Akkgen Bio Description and Business Overview
Table 77. Akkgen Bio Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 78. Akkgen Bio Canagliflozin Hemihydrate Product
Table 79. Akkgen Bio Recent Developments/Updates
Table 80. Hangzhou Dawn Ray Pharmaceutical Corporation Information
Table 81. Hangzhou Dawn Ray Pharmaceutical Description and Business Overview
Table 82. Hangzhou Dawn Ray Pharmaceutical Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 83. Hangzhou Dawn Ray Pharmaceutical Canagliflozin Hemihydrate Product
Table 84. Hangzhou Dawn Ray Pharmaceutical Recent Developments/Updates
Table 85. ACE Biolabs Corporation Information
Table 86. ACE Biolabs Description and Business Overview
Table 87. ACE Biolabs Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 88. ACE Biolabs Canagliflozin Hemihydrate Product
Table 89. ACE Biolabs Recent Developments/Updates
Table 90. Beijing Huikang Boyuan Chemical Tech Corporation Information
Table 91. Beijing Huikang Boyuan Chemical Tech Description and Business Overview
Table 92. Beijing Huikang Boyuan Chemical Tech Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 93. Beijing Huikang Boyuan Chemical Tech Canagliflozin Hemihydrate Product
Table 94. Beijing Huikang Boyuan Chemical Tech Recent Developments/Updates
Table 95. Shanghai Yuhan Chemical Corporation Information
Table 96. Shanghai Yuhan Chemical Description and Business Overview
Table 97. Shanghai Yuhan Chemical Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 98. Shanghai Yuhan Chemical Canagliflozin Hemihydrate Product
Table 99. Shanghai Yuhan Chemical Recent Developments/Updates
Table 100. DC Chemicals Corporation Information
Table 101. DC Chemicals Description and Business Overview
Table 102. DC Chemicals Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 103. DC Chemicals Canagliflozin Hemihydrate Product
Table 104. DC Chemicals Recent Developments/Updates
Table 105. Adooq Bioscience Corporation Information
Table 106. Adooq Bioscience Description and Business Overview
Table 107. Adooq Bioscience Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 108. Adooq Bioscience Canagliflozin Hemihydrate Product
Table 109. Adooq Bioscience Recent Developments/Updates
Table 110. Dr. Reddy's Corporation Information
Table 111. Dr. Reddy's Description and Business Overview
Table 112. Dr. Reddy's Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 113. Dr. Reddy's Canagliflozin Hemihydrate Product
Table 114. Dr. Reddy's Recent Developments/Updates
Table 115. Carbosynth Corporation Information
Table 116. Carbosynth Description and Business Overview
Table 117. Carbosynth Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 118. Carbosynth Canagliflozin Hemihydrate Product
Table 119. Carbosynth Recent Developments/Updates
Table 120. Toronto Research Chemicals Corporation Information
Table 121. Toronto Research Chemicals Description and Business Overview
Table 122. Toronto Research Chemicals Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 123. Toronto Research Chemicals Canagliflozin Hemihydrate Product
Table 124. Toronto Research Chemicals Recent Developments/Updates
Table 125. Selleck Chemicals Corporation Information
Table 126. Selleck Chemicals Description and Business Overview
Table 127. Selleck Chemicals Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 128. Selleck Chemicals Canagliflozin Hemihydrate Product
Table 129. Selleck Chemicals Recent Developments/Updates
Table 130. SimSon Pharma Corporation Information
Table 131. SimSon Pharma Description and Business Overview
Table 132. SimSon Pharma Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 133. SimSon Pharma Canagliflozin Hemihydrate Product
Table 134. SimSon Pharma Recent Developments/Updates
Table 135. VIVAN Life Sciences Corporation Information
Table 136. VIVAN Life Sciences Description and Business Overview
Table 137. VIVAN Life Sciences Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 138. VIVAN Life Sciences Canagliflozin Hemihydrate Product
Table 139. VIVAN Life Sciences Recent Developments/Updates
Table 140. InvivoChem Corporation Information
Table 141. InvivoChem Description and Business Overview
Table 142. InvivoChem Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 143. InvivoChem Canagliflozin Hemihydrate Product
Table 144. InvivoChem Recent Developments/Updates
Table 145. Clinivex Corporation Information
Table 146. Clinivex Description and Business Overview
Table 147. Clinivex Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 148. Clinivex Canagliflozin Hemihydrate Product
Table 149. Clinivex Recent Developments/Updates
Table 150. Aprazer Healthcare Corporation Information
Table 151. Aprazer Healthcare Description and Business Overview
Table 152. Aprazer Healthcare Canagliflozin Hemihydrate Sales (MG), Revenue (US$ Million), Price (US$/MG) and Gross Margin (2018-2023)
Table 153. Aprazer Healthcare Canagliflozin Hemihydrate Product
Table 154. Aprazer Healthcare Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Canagliflozin Hemihydrate Distributors List
Table 158. Canagliflozin Hemihydrate Customers List
Table 159. Canagliflozin Hemihydrate Market Trends
Table 160. Canagliflozin Hemihydrate Market Drivers
Table 161. Canagliflozin Hemihydrate Market Challenges
Table 162. Canagliflozin Hemihydrate Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Canagliflozin Hemihydrate
Figure 2. Global Canagliflozin Hemihydrate Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Canagliflozin Hemihydrate Market Share by Type in 2022 & 2029
Figure 4. High Purity Canagliflozin Hemihydrate Product Picture
Figure 5. Ultra High Purity Canagliflozin Hemihydrate Product Picture
Figure 6. Global Canagliflozin Hemihydrate Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Canagliflozin Hemihydrate Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Canagliflozin Hemihydrate Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Canagliflozin Hemihydrate Market Size (2018-2029) & (US$ Million)
Figure 13. Global Canagliflozin Hemihydrate Sales (2018-2029) & (MG)
Figure 14. Global Canagliflozin Hemihydrate Average Price (US$/MG) & (2018-2029)
Figure 15. Canagliflozin Hemihydrate Report Years Considered
Figure 16. Canagliflozin Hemihydrate Sales Share by Manufacturers in 2022
Figure 17. Global Canagliflozin Hemihydrate Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Canagliflozin Hemihydrate Players: Market Share by Revenue in 2022
Figure 19. Canagliflozin Hemihydrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Canagliflozin Hemihydrate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Canagliflozin Hemihydrate Sales Market Share by Country (2018-2029)
Figure 22. North America Canagliflozin Hemihydrate Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Canagliflozin Hemihydrate Sales Market Share by Country (2018-2029)
Figure 26. Europe Canagliflozin Hemihydrate Revenue Market Share by Country (2018-2029)
Figure 27. Germany Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Canagliflozin Hemihydrate Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Canagliflozin Hemihydrate Revenue Market Share by Region (2018-2029)
Figure 34. China Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Canagliflozin Hemihydrate Sales Market Share by Country (2018-2029)
Figure 45. Latin America Canagliflozin Hemihydrate Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Canagliflozin Hemihydrate Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Canagliflozin Hemihydrate Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Canagliflozin Hemihydrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Canagliflozin Hemihydrate by Type (2018-2029)
Figure 55. Global Revenue Market Share of Canagliflozin Hemihydrate by Type (2018-2029)
Figure 56. Global Canagliflozin Hemihydrate Price (US$/MG) by Type (2018-2029)
Figure 57. Global Sales Market Share of Canagliflozin Hemihydrate by Application (2018-2029)
Figure 58. Global Revenue Market Share of Canagliflozin Hemihydrate by Application (2018-2029)
Figure 59. Global Canagliflozin Hemihydrate Price (US$/MG) by Application (2018-2029)
Figure 60. Canagliflozin Hemihydrate Value Chain
Figure 61. Canagliflozin Hemihydrate Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 硫酸カルシウム半水和物のグローバル市場展望 2023年-2029年：建築、医療用、工業用、食品用、その他
  • ピロキシカムAPIの世界市場2023年：純度≧99%、純度≧99.5%
  • 屋内玄関マットの世界市場2023年：ゴム裏玄関マット、ビニール裏玄関マット、その他型
  • 経口溶解フィルム製剤の世界市場2023年：口腔分散性フィルム、口腔粘膜フィルム
  • ガスシリンジの世界市場2023年：キャピラリーチューブ付きガスシリンジ、ストレート型ストップコック付きガスシリンジ、三方活栓付きガスシリンジ、標準型ストップコック付きガスシリンジ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8707 )"カナグリフロジン半水和物の世界市場2023年：高純度カナグリフロジン半水和物、超高純度カナグリフロジン半水和物" (英文：Global Canagliflozin Hemihydrate Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。